English

This toolkit supports Ryan White HIV/AIDS Program (RWHAP) Part B AIDS Drug Assistance Programs (ADAPs)—which provide access to HIV-related medications for low-income individuals—in navigating the planning, selection, and implementation of benefits management contracts. It offers key definitions, planning tools, real-world examples, and checklists to help ADAP administrators—new or experienced—align contractor selection with their program’s unique infrastructure and needs.

This webpage explains common causes—such as STIs, infections, or irritation—along with symptoms, diagnosis, and treatment options. It emphasizes the importance of timely medical care to address underlying issues and prevent complications.

In this webinar, CDC and HRSA speakers review the calendar year 2027–2031 Integrated HIV Prevention & Care Plan Guidance—highlighting key updates, submission requirements, and real-world recipient examples. The training equips CDC- and HRSA-funded jurisdictions with technical support, planning tools, and strategies to develop coordinated HIV prevention and care efforts by the June 30, 2026 deadline.

This guideline compiles up-to-date legal requirements across all U.S. states and territories, clarifying when healthcare providers and laboratories must report negative Hepatitis C test outcomes. It offers a clear, state-by-state breakdown to help public health entities and providers comply with surveillance obligations and improve data completeness.

This guideline presents a comprehensive state-by-state legal analysis of obligations for healthcare providers and laboratories to report negative HIV test outcomes. It clearly highlights jurisdictional differences, helping public health officials and clinicians ensure compliance with surveillance mandates and improve disease tracking.

This tool is intended to facilitate the calculation of the number of infections and other health outcomes averted, and the associated savings in direct medical costs and productivity costs, by STI prevention program activities as described in this User Guide and supporting scientific manuscript and appendix. 

This report evaluates the current needs, protocols, and promising practices for latent tuberculosis infection (LTBI) and tuberculosis (TB) screening, testing, and treatment among community health centers serving Asian American/Asian (A/AA) and Native Hawaiian/Pacific Islander (NH/PI) populations.

This report summarizes the TB Elimination Alliance's (TEA) activities and outcomes from 2019 to 2024.

This webpage explains Assembly Bill 2132, which mandates tuberculosis (TB) risk assessment and testing for adult primary care patients in California.

This video discusses how congenital syphilis rates continue to rise, but many cases can be prevented with education and early screening.